Owens & Minor (NYSE:OMI) Updates FY 2024 Earnings Guidance

Owens & Minor (NYSE:OMI) updated its FY 2024 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of 1.500-1.530 for the period, compared to the consensus estimate of 1.510. The company issued revenue guidance of $10.7 billion-$10.7 billion, compared to the consensus revenue estimate of $10.7 billion. Owens & Minor also updated its Q4 2024 guidance to 0.520-0.550 EPS.

Owens & Minor Stock Performance

Shares of OMI stock opened at $9.23 on Tuesday. The firm has a fifty day moving average of $13.77 and a 200-day moving average of $14.28. The company has a debt-to-equity ratio of 2.11, a quick ratio of 0.45 and a current ratio of 1.09. Owens & Minor has a 52-week low of $8.76 and a 52-week high of $28.35.

Owens & Minor (NYSE:OMI) last posted its quarterly earnings data on Monday, November 4th. The company reported $0.42 EPS for the quarter, beating the consensus estimate of $0.41 by $0.01. Owens & Minor had a negative net margin of 0.46% and a positive return on equity of 14.60%. The business had revenue of $2.72 billion for the quarter, compared to analysts’ expectations of $2.68 billion. During the same period in the previous year, the firm posted $0.44 EPS. The firm’s revenue was up 5.0% compared to the same quarter last year. On average, equities research analysts forecast that Owens & Minor will post 1.49 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on the company. Barclays lowered their price objective on Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating for the company in a research note on Tuesday, November 5th. Robert W. Baird decreased their price target on shares of Owens & Minor from $19.00 to $14.00 and set a “neutral” rating for the company in a research note on Tuesday, November 5th. UBS Group decreased their price target on Owens & Minor from $28.00 to $25.00 and set a “buy” rating for the company in a report on Tuesday, November 5th. Finally, Citigroup cut their price objective on Owens & Minor from $21.00 to $18.50 and set a “buy” rating on the stock in a research report on Tuesday, November 5th. Two analysts have rated the stock with a sell rating, five have assigned a hold rating and two have given a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $18.50.

Insider Buying and Selling at Owens & Minor

In other news, CFO Jonathan A. Leon sold 5,282 shares of the business’s stock in a transaction dated Thursday, November 21st. The stock was sold at an average price of $11.82, for a total value of $62,433.24. Following the transaction, the chief financial officer now directly owns 130,822 shares in the company, valued at $1,546,316.04. The trade was a 3.88 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 2.62% of the company’s stock.

Owens & Minor Company Profile

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.